BASALIN
Live / Registered — Registered — Section 71 accepted (as of 07 Apr 2025)
What this means for you
Registered since 07 Oct 2014. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79136321
- Registration number
- 4615574
- Mark type
- Word mark
- Filed
- 25 Jul 2013
- Published for opposition
- 22 Jul 2014
- Registered
- 07 Oct 2014
- Attorney of record
- Andrew T. Rissler
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, insulin; raw material medicine, namely, insulin; Biomedicine for treating diabetes; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines cognitive disorders; chemical preparations for medical purposes, namely, for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical purposes, namely, for the treatment of endocrine related diseases and disorders; Pharmaceutical preparations, namely, insulin for injection; [ dietetic substances, namely, dietetic sugar, pasta and crackers adapted for medical use; ] drugs, namely, anti-diabetic pharmaceuticals for medical purposes
Owner
- Gan & Lee Pharmaceuticals., Tongzhou D., Beijing, CN
- Gan & Lee Pharmaceuticals Ltd., CN
- Gan & Lee Pharmaceuticals Ltd., CN
Prosecution history
- 07 Dec 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 19 Jun 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 07 Apr 2025 — REGISTERED-SEC.71 ACCEPTED
- 07 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Jan 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Nov 2024 — TEAS SECTION 71 RECEIVED
- 07 Oct 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 12 May 2023 — INTERNATIONAL REGISTRATION RENEWED
- 03 Nov 2021 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 27 Sept 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 27 Sept 2021 — INVALIDATION PROCESSED
- 11 Sept 2021 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 11 Jan 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 11 Jan 2021 — REGISTERED-SEC.71 ACCEPTED